Company Presentation

Adoram Therapeutics, a UNIGE spin-off, is discovering therapies for solid tumors, inflammation, and metabolic disorders. Our next generation small molecule therapies are discovered in-house using sensitive screening assays that outperform industry standards. The sought-after allosteric nature of these molecules imparts enhanced efficacy & safety compared to conventional small molecules.